Barclays
CPXX

Barclays’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Barclays’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-152,849
Closed -$4.61M – 7061
2016
Q2 		$4.61M Buy
+152,849
New +$3.1M 0.01% 1373

Barclays's CPXX Position: Q3 2016 in Review

Barclays sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 152,849 shares — an estimated $4.61M sold.

Barclays first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $4.61M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Barclays reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Barclays sold 152,849 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $4.61M.
  • Barclays first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Barclays's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $4.61M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.